El interés en corto de Ingredion da a los inversores una idea del grado en que los inversores apuestan por la caída de las acciones de Ingredion. Los datos de interés en corto se actualizan cada dos semanas.

Ingredion (NYSE:INGR) Bolsa, Informe de interés en corto

Ingredion

Ingredion is an ingredients provider for the food, beverage, brewing, and animal nutrition industries. The company processes corn, tapioca, potatoes, stevia, grains, fruits, gums, and vegetables into value-added ingredients. The company has two main product lines: specialty and core ingredients. Specialty ingredients includes starch-based texturizers, natural alternative sweeteners such as stevia, and plant proteins for alternative dairy and snacks. Core ingredients includes sweeteners, such as high-fructose corn syrup, and commodity starches, such as those used for sustainable packaging.

Ingredion Inc

Ingram Micro Holding Corporation Common Stock

Ingram Micro Holding Corp

BMO Capital analyst Andrew Strelzik maintains Ingredion (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/INGR#NYSE">INGR</a>) with a Market Perform and raises the price target from $128 to $147.

News

Price Target

Analyst Ratings

INGR

BMO Capital Maintains Market Perform on Ingredion, Raises Price Target to $147

Analysts' ratings for Ingredion (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/INGR#NYSE">INGR</a>) over the last quarter vary from bullish to bearish, as provided by 5 analysts.
The following table encapsulates their recent ratings, offering a glimpse into the evolving sentiments over the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th style="text-align: right;">Bullish</th>
<th style="text-align: right;">Somewhat Bullish</th>
<th style="text-align: right;">Indifferent</th>
<th style="text-align: right;">Somewhat Bearish</th>
<th style="text-align: right;">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">4</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">2</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
</tbody>
</table>
In the assessment of 12-month price targets, analysts unveil insights for Ingredion, presenting an average target of $157.2, a high estimate of $178.00, and a low estimate of $145.00. Observing a 13.42% increase, the current average has risen from the previous average price target of $138.60. 
<img src="https://www.benzinga.com/files/images/story/2024/1730905288_0.png" alt="price target chart" />
<h2>Diving into Analyst Ratings: An In-Depth Exploration</h2>
The standing of Ingredion among financial experts becomes clear with a thorough analysis of recent analyst actions. The summary below outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Benjamin Theurer</td>
<td>Barclays</td>
<td>Raises</td>
<td>Overweight</td>
<td>$168.00</td>
<td>$145.00</td>
</tr>
<tr>
<td>Kristen Owen</td>
<td>Oppenheimer</td>
<td>Raises</td>
<td>Outperform</td>
<td>$178.00</td>
<td>$147.00</td>
</tr>
<tr>
<td>Kristen Owen</td>
<td>Oppenheimer</td>
<td>Raises</td>
<td>Outperform</td>
<td>$147.00</td>
<td>$138.00</td>
</tr>
<tr>
<td>Cody Ross</td>
<td>UBS</td>
<td>Raises</td>
<td>Buy</td>
<td>$148.00</td>
<td>$141.00</td>
</tr>
<tr>
<td>Benjamin Theurer</td>
<td>Barclays</td>
<td>Raises</td>
<td>Overweight</td>
<td>$145.00</td>
<td>$122.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Analysts respond to changes in market conditions and company performance, frequently updating their recommendations. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their reaction to recent developments related to Ingredion. This information offers a snapshot of how analysts perceive the current state of the company.</li>
<li>Rating: Analysts unravel qualitative evaluations for stocks, ranging from 'Outperform' to 'Underperform'. These ratings offer insights into expectations for the relative performance of Ingredion compared to the broader market.</li>
<li>Price Targets: Analysts gauge the dynamics of price targets, providing estimates for the future value of Ingredion's stock. This comparison reveals trends in analysts' expectations over time.</li>
</ul>
Navigating through these analyst evaluations alongside other financial indicators can contribute to a holistic understanding of Ingredion's market standing. Stay informed and make data-driven decisions with our Ratings Table.
<a href="https://www.benzinga.com/quote/INGR/analyst-ratings?utm_source=Benzinga Insights">Stay up to date on Ingredion analyst ratings.</a>
<h2>Delving into Ingredion's Background</h2>
Ingredion is an ingredients provider for the food, beverage, brewing, and animal nutrition industries. The company processes corn, tapioca, potatoes, stevia, grains, fruits, gums, and vegetables into value-added ingredients. The company has two main product lines: specialty and core ingredients. Specialty ingredients includes starch-based texturizers, natural alternative sweeteners such as stevia, and plant proteins for alternative dairy and snacks. Core ingredients includes sweeteners, such as high-fructose corn syrup, and commodity starches, such as those used for sustainable packaging.
<h3>A Deep Dive into Ingredion's Financials</h3>
Market Capitalization: Surpassing industry standards, the company's market capitalization asserts its dominance in terms of size, suggesting a robust market position.
Negative Revenue Trend: Examining Ingredion's financials over 3 months reveals challenges. As of 30 June, 2024, the company experienced a decline of approximately -9.23% in revenue growth, reflecting a decrease in top-line earnings. When compared to others in the Consumer Staples sector, the company faces challenges, achieving a growth rate lower than the average among peers.
Net Margin: Ingredion's net margin is impressive, surpassing industry averages. With a net margin of 7.88%, the company demonstrates strong profitability and effective cost management.
Return on Equity (ROE): Ingredion's ROE stands out, surpassing industry averages. With an impressive ROE of 3.94%, the company demonstrates effective use of equity capital and strong financial performance.
Return on Assets (ROA): The company's ROA is a standout performer, exceeding industry averages. With an impressive ROA of 2.04%, the company showcases effective utilization of assets.
Debt Management: Ingredion's debt-to-equity ratio is below industry norms, indicating a sound financial structure with a ratio of 0.49.
<h2>Understanding the Relevance of Analyst Ratings</h2>
Analysts are specialists within banking and financial systems that typically report for specific stocks or within defined sectors. These people research company financial statements, sit in conference calls and meetings, and speak with relevant insiders to determine what are known as analyst ratings for stocks. Typically, analysts will rate each stock once a quarter. 
Analysts may supplement their ratings with predictions for metrics like growth estimates, earnings, and revenue, offering investors a more comprehensive outlook. However, investors should be mindful that analysts, like any human, can have subjective perspectives influencing their forecasts.
Breaking: Wall Street's Next Big Mover
Benzinga's #1 analyst just identified a stock poised for explosive growth. This under-the-radar company could surge 200%+ as major market shifts unfold. <a href="https://www.benzinga.com/premium/ideas/turning-point-trader-checkout-2/?t=Tu1tu3arja3be22tu36&amp;utm_source=benzinga-insights">Click here for urgent details</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Beyond The Numbers: 5 Analysts Discuss Ingredion Stock

Barclays analyst Benjamin Theurer maintains Ingredion (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/INGR#NYSE">INGR</a>) with a Overweight and raises the price target from $145 to $168.

Barclays Maintains Overweight on Ingredion, Raises Price Target to $168

Oppenheimer analyst Kristen Owen maintains Ingredion (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/INGR#NYSE">INGR</a>) with a Outperform and raises the price target from $147 to $178.

Oppenheimer Maintains Outperform on Ingredion, Raises Price Target to $178

U.S. stocks were higher, with the Dow Jones index gaining around 300 points on Tuesday.
Shares of Emerson Electric Co (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EMR#NYSE">EMR</a>) rose sharply during Monday's session after the company reported better-than-expected fourth-quarter financial results and issued FY25 adjusted EPS guidance above estimates. Also, the company announced it increased return of capital to shareholders with plans to repurchase <a href="https://www.benzinga.com/news/earnings/24/11/41748679/emerson-electric-gains-on-q4-earnings-beat-and-fy25-growth-forecast-eyes-aspentech-buyout">approximately $2B in FY25.</a>
Net sales growth of 13% year over year to $4.62 billion, beating the consensus of $4.57 billion. Underlying sales were up 4%, and underlying orders increased by 2% in the quarter. Adjusted EPS improved 15% to $1.48, beating the consensus of $1.47.
Emerson Electric shares jumped 6.6% to $117.01 on Tuesday.
Here are some other big stocks recording gains in today's session.
<ul>
<li>Vimeo, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VMEO#NASDAQ">VMEO</a>) shares jumped 42.7% to $6.86 after the company reported better-than-expected third-quarter financial results and issued fourth-quarter sales guidance above estimates.</li>
<li>Gogo Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GOGO#NASDAQ">GOGO</a>) gained 29.3% to $8.47 after the company reported better-than-expected third-quarter financial results.</li>
<li>Astera Labs Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ALAB#NASDAQ">ALAB</a>) rose 29.1% to $90.14 after the company reported better-than-expected third-quarter EPS and sales.</li>
<li>Aris Water Solutions Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ARIS#NYSE">ARIS</a>) gained 25.8% to $20.84 following strong quarterly results.</li>
<li>Palantir Technologies Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PLTR#NYSE">PLTR</a>) gained 22.4% to $50.70 after the company reported better-than-expected third-quarter financial results and issued guidance above consensus estimates.</li>
<li>UFP Technologies Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/UFPT#NASDAQ">UFPT</a>) rose 20.7% to $335.00 after the company reported better-than-expected third-quarter financial results.</li>
<li>Lindblad Expeditions Holdings Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LIND#NASDAQ">LIND</a>) gained 20.6% to $11.28 after the company reported better-than-expected third-quarter financial results.</li>
<li>DXP Enterprises Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DXPE#NASDAQ">DXPE</a>) gained 18.7% to $60.45 following strong quarterly results.</li>
<li>Century Aluminum Co (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CENX#NASDAQ">CENX</a>) gained 17.7% to $20.66 following upbeat quarterly earnings.</li>
<li>Payoneer Global Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PAYO#NASDAQ">PAYO</a>) climbed 16% to $9.88 after the company reported better-than-expected quarterly EPS and sales and raised its FY24 revenue guidance.</li>
<li>Cushman &amp; Wakefield PLC (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CWK#NYSE">CWK</a>) gained 13.2% to $14.88 after the company reported better-than-expected quarterly adjusted EPS results.</li>
<li>Ingredion Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/INGR#NYSE">INGR</a>) rose 12.6% to $150.97 following upbeat earnings.</li>
<li>Primoris Services Corp (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PRIM#NYSE">PRIM</a>) gained 10.5% to $71.11 following strong quarterly earnings.</li>
<li>Powell Industries, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/POWL#NASDAQ">POWL</a>) rose 9.1% to $293.34.</li>
<li>Cummins Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CMI#NYSE">CMI</a>) gained 8.7% to $353.91 after the company reported better-than-expected third-quarter financial results.</li>
<li>Nomura Holdings Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NMR#NYSE">NMR</a>) rose 7.3% to $5.64 following second-quarter results.</li>
<li>Apollo Global Management (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/APO#NYSE">APO</a>) gained 6.8% to $149.00 after the company reported better-than-expected quarterly financial results.</li>
</ul>
Now Read This: 
<ul>
<li><a href="https://www.benzinga.com/trading-ideas/long-ideas/24/11/41744659/jim-cramer-says-he-cant-recommend-this-major-automaker-ceva-is-way-too-high">Jim Cramer Says He Can&#8217;t Recommend This Major Automaker, Ceva Is &#8216;Way Too High&#8217;</a></li>
</ul>

Intraday Update

Markets

Movers

Trading Ideas

ALAB

ARIS

CENX

DXPE

GOGO

LIND

PAYO

PLTR

POWL

PRIM

UFPT

VMEO

Emerson Electric Posts Better-Than-Expected Results, Joins Palantir Technologies, DXP Enterprises, Cummins, Apollo Global Management And Other Big Stocks Moving Higher On Tuesday

WIIM

Ingredion shares are trading higher after the company reported better-than-expected Q3 adjusted EPS results and raised its FY24 adjusted EPS guidance above estimates.

Guidance

Ingredion Now Expects FY24 Net Sales To Be Down Mid-Single-Digits (Prior View: Down Low Single-Digits), Excluding Effects Of Sale Of South Korea Business

Ingredion Raises FY24 Adjusted EPS Outlook From $9.70 - $10.20 To $10.35 - $10.65, Est $9.97

Ingredion (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/INGR#NYSE">INGR</a>) reported quarterly earnings of $3.05 per share which beat the analyst consensus estimate of $2.58 by 18.22 percent. This is a 30.9 percent increase over earnings of $2.33 per share from the same period last year. The company reported quarterly sales of $1.87 billion which missed the analyst consensus estimate of $1.95 billion by 3.92 percent. This is a 8.02 percent decrease over sales of $2.03 billion the same period last year.

Earnings

Earnings Beats

Earnings Misses

Ingredion Q3 2024 Adj EPS $3.05 Beats $2.58 Estimate, Sales $1.87B Miss $1.95B Estimate

In the latest quarter, 5 analysts provided ratings for Ingredion (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/INGR#NYSE">INGR</a>), showcasing a mix of bullish and bearish perspectives.
The table below provides a concise overview of recent ratings by analysts, offering insights into the changing sentiments over the past 30 days and drawing comparisons with the preceding months for a holistic perspective.
<table>
<thead>
<tr>
<th></th>
<th style="text-align: right;">Bullish</th>
<th style="text-align: right;">Somewhat Bullish</th>
<th style="text-align: right;">Indifferent</th>
<th style="text-align: right;">Somewhat Bearish</th>
<th style="text-align: right;">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">3</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">2</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
</tbody>
</table>
Analysts have recently evaluated Ingredion and provided 12-month price targets. The average target is $141.2, accompanied by a high estimate of $148.00 and a low estimate of $128.00. Witnessing a positive shift, the current average has risen by 9.12% from the previous average price target of $129.40.
<img src="https://www.benzinga.com/files/images/story/2024/1729544412_0.png" alt="price target chart" />
<h2>Breaking Down Analyst Ratings: A Detailed Examination</h2>
An in-depth analysis of recent analyst actions unveils how financial experts perceive Ingredion. The following summary outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Kristen Owen</td>
<td>Oppenheimer</td>
<td>Raises</td>
<td>Outperform</td>
<td>$147.00</td>
<td>$138.00</td>
</tr>
<tr>
<td>Cody Ross</td>
<td>UBS</td>
<td>Raises</td>
<td>Buy</td>
<td>$148.00</td>
<td>$141.00</td>
</tr>
<tr>
<td>Benjamin Theurer</td>
<td>Barclays</td>
<td>Raises</td>
<td>Overweight</td>
<td>$145.00</td>
<td>$122.00</td>
</tr>
<tr>
<td>Andrew Strelzik</td>
<td>BMO Capital</td>
<td>Raises</td>
<td>Market Perform</td>
<td>$128.00</td>
<td>$120.00</td>
</tr>
<tr>
<td>Kristen Owen</td>
<td>Oppenheimer</td>
<td>Raises</td>
<td>Outperform</td>
<td>$138.00</td>
<td>$126.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Analysts frequently update their recommendations based on evolving market conditions and company performance. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their reaction to recent developments related to Ingredion. This information provides a snapshot of how analysts perceive the current state of the company.</li>
<li>Rating: Providing a comprehensive analysis, analysts offer qualitative assessments, ranging from 'Outperform' to 'Underperform'. These ratings reflect expectations for the relative performance of Ingredion compared to the broader market.</li>
<li>Price Targets: Analysts set price targets as an estimate of a stock's future value. Comparing the current and prior price targets provides insight into how analysts' expectations have changed over time. This information can be valuable for investors seeking to understand consensus views on the stock's potential future performance.</li>
</ul>
Understanding these analyst evaluations alongside key financial indicators can offer valuable insights into Ingredion's market standing. Stay informed and make well-considered decisions with our Ratings Table.
<a href="https://www.benzinga.com/quote/INGR/analyst-ratings?utm_source=Benzinga Insights">Stay up to date on Ingredion analyst ratings.</a>
<h2>Get to Know Ingredion Better</h2>
Ingredion is an ingredients provider for the food, beverage, brewing, and animal nutrition industries. The company processes corn, tapioca, potatoes, stevia, grains, fruits, gums, and vegetables into value-added ingredients. The company has two main product lines: specialty and core ingredients. Specialty ingredients includes starch-based texturizers, natural alternative sweeteners such as stevia, and plant proteins for alternative dairy and snacks. Core ingredients includes sweeteners, such as high-fructose corn syrup, and commodity starches, such as those used for sustainable packaging.
<h3>Ingredion: Financial Performance Dissected</h3>
Market Capitalization Highlights: Above the industry average, the company's market capitalization signifies a significant scale, indicating strong confidence and market prominence.
Negative Revenue Trend: Examining Ingredion's financials over 3 months reveals challenges. As of 30 June, 2024, the company experienced a decline of approximately -9.23% in revenue growth, reflecting a decrease in top-line earnings. In comparison to its industry peers, the company trails behind with a growth rate lower than the average among peers in the Consumer Staples sector.
Net Margin: Ingredion's net margin surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive 7.88% net margin, the company effectively manages costs and achieves strong profitability.
Return on Equity (ROE): The company's ROE is a standout performer, exceeding industry averages. With an impressive ROE of 3.94%, the company showcases effective utilization of equity capital.
Return on Assets (ROA): Ingredion's ROA excels beyond industry benchmarks, reaching 2.04%. This signifies efficient management of assets and strong financial health.
Debt Management: Ingredion's debt-to-equity ratio is below industry norms, indicating a sound financial structure with a ratio of 0.49.
<h2>What Are Analyst Ratings?</h2>
Ratings come from analysts, or specialists within banking and financial systems that report for specific stocks or defined sectors (typically once per quarter for each stock). Analysts usually derive their information from company conference calls and meetings, financial statements, and conversations with important insiders to reach their decisions.
Analysts may enhance their evaluations by incorporating forecasts for metrics like growth estimates, earnings, and revenue, delivering additional guidance to investors. It is vital to acknowledge that, although experts in stocks and sectors, analysts are human and express their opinions when providing insights.
Which Stocks Are Analysts Recommending Now?
Benzinga Edge gives you instant access to all major analyst upgrades, downgrades, and price targets. Sort by accuracy, upside potential, and more. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=be8be9arja3be22bz21&amp;utm_source=benzinga-insights">Click here to stay ahead of the market</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Analyst Scoreboard: 5 Ratings For Ingredion

Providing a diverse range of perspectives from bullish to bearish, 5 analysts have published ratings on Ingredion (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/INGR#NYSE">INGR</a>) in the last three months.
The table below provides a snapshot of their recent ratings, showcasing how sentiments have evolved over the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">1</td>
<td align="right">3</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">1</td>
<td align="right">2</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
In the assessment of 12-month price targets, analysts unveil insights for Ingredion, presenting an average target of $141.2, a high estimate of $148.00, and a low estimate of $128.00. This current average reflects an increase of 9.12% from the previous average price target of $129.40. 
<img src="https://www.benzinga.com/files/images/story/2024/1729533662_0.png" alt="price target chart" />
<h2>Exploring Analyst Ratings: An In-Depth Overview</h2>
A clear picture of Ingredion's perception among financial experts is painted with a thorough analysis of recent analyst actions. The summary below outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Kristen Owen</td>
<td>Oppenheimer</td>
<td>Raises</td>
<td>Outperform</td>
<td>$147.00</td>
<td>$138.00</td>
</tr>
<tr>
<td>Cody Ross</td>
<td>UBS</td>
<td>Raises</td>
<td>Buy</td>
<td>$148.00</td>
<td>$141.00</td>
</tr>
<tr>
<td>Benjamin Theurer</td>
<td>Barclays</td>
<td>Raises</td>
<td>Overweight</td>
<td>$145.00</td>
<td>$122.00</td>
</tr>
<tr>
<td>Andrew Strelzik</td>
<td>BMO Capital</td>
<td>Raises</td>
<td>Market Perform</td>
<td>$128.00</td>
<td>$120.00</td>
</tr>
<tr>
<td>Kristen Owen</td>
<td>Oppenheimer</td>
<td>Raises</td>
<td>Outperform</td>
<td>$138.00</td>
<td>$126.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Analysts respond to changes in market conditions and company performance, frequently updating their recommendations. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their reaction to recent developments related to Ingredion. This information offers a snapshot of how analysts perceive the current state of the company.</li>
<li>Rating: Offering a comprehensive view, analysts assess stocks qualitatively, spanning from 'Outperform' to 'Underperform'. These ratings convey expectations for the relative performance of Ingredion compared to the broader market.</li>
<li>Price Targets: Analysts provide insights into price targets, offering estimates for the future value of Ingredion's stock. This comparison reveals trends in analysts' expectations over time.</li>
</ul>
To gain a panoramic view of Ingredion's market performance, explore these analyst evaluations alongside essential financial indicators. Stay informed and make judicious decisions using our Ratings Table.
<a href="https://www.benzinga.com/quote/INGR/analyst-ratings?utm_source=Benzinga Insights">Stay up to date on Ingredion analyst ratings.</a>
<h2>Delving into Ingredion's Background</h2>
Ingredion is an ingredients provider for the food, beverage, brewing, and animal nutrition industries. The company processes corn, tapioca, potatoes, stevia, grains, fruits, gums, and vegetables into value-added ingredients. The company has two main product lines: specialty and core ingredients. Specialty ingredients includes starch-based texturizers, natural alternative sweeteners such as stevia, and plant proteins for alternative dairy and snacks. Core ingredients includes sweeteners, such as high-fructose corn syrup, and commodity starches, such as those used for sustainable packaging.
<h3>Financial Milestones: Ingredion's Journey</h3>
Market Capitalization: Exceeding industry standards, the company's market capitalization places it above industry average in size relative to peers. This emphasizes its significant scale and robust market position.
Revenue Challenges: Ingredion's revenue growth over 3 months faced difficulties. As of 30 June, 2024, the company experienced a decline of approximately -9.23%. This indicates a decrease in top-line earnings. As compared to competitors, the company encountered difficulties, with a growth rate lower than the average among peers in the Consumer Staples sector.
Net Margin: Ingredion's net margin surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive 7.88% net margin, the company effectively manages costs and achieves strong profitability.
Return on Equity (ROE): The company's ROE is a standout performer, exceeding industry averages. With an impressive ROE of 3.94%, the company showcases effective utilization of equity capital.
Return on Assets (ROA): The company's ROA is a standout performer, exceeding industry averages. With an impressive ROA of 2.04%, the company showcases effective utilization of assets.
Debt Management: Ingredion's debt-to-equity ratio is below industry norms, indicating a sound financial structure with a ratio of 0.49.
<h2>Understanding the Relevance of Analyst Ratings</h2>
Experts in banking and financial systems, analysts specialize in reporting for specific stocks or defined sectors. Their comprehensive research involves attending company conference calls and meetings, analyzing financial statements, and engaging with insiders to generate what are known as analyst ratings for stocks. Typically, analysts assess and rate each stock once per quarter.
Some analysts publish their predictions for metrics such as growth estimates, earnings, and revenue to provide additional guidance with their ratings. When using analyst ratings, it is important to keep in mind that stock and sector analysts are also human and are only offering their opinions to investors.
Which Stocks Are Analysts Recommending Now?
Benzinga Edge gives you instant access to all major analyst upgrades, downgrades, and price targets. Sort by accuracy, upside potential, and more. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=be8be9arja3be22bz21&amp;utm_source=benzinga-insights">Click here to stay ahead of the market</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

What Analysts Are Saying About Ingredion Stock

Oppenheimer analyst Kristen Owen maintains Ingredion (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/INGR#NYSE">INGR</a>) with a Outperform and raises the price target from $138 to $147.

Oppenheimer Maintains Outperform on Ingredion, Raises Price Target to $147

International Flavors &amp; Fragrances Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/iff#NYSE">IFF</a>) shares scaled a new 52-week high of $104.17 on Friday before closing the session lower at $103.99.
IFF has a market capitalization of $26.6 billion. The company&#39;s shares have gained 52.6%, outperforming the industry&#39;s growth of 0.9% and the S&amp;P 500 index&#39;s rise of 26.9%.
<img alt="Zacks Investment Research" src="https://staticx-tuner.zacks.com/images/articles/charts/ab/76367.jpg?v=287330217" />
Image Source: Zacks Investment Research
<h2>What&#39;s Aiding International Flavors?</h2>
Demand for Flavors &amp; Fragrances to Drive IFF&#39;s Growth: The company is well-poised to benefit from demand for a variety of consumer products containing flavors and fragrances, going forward. Anticipated growth in emerging markets will likely be a key catalyst. Consequently, International Flavors is focused on gaining a share in emerging markets.
Backed by the company&#39;s global presence, diversified business platform, broad product portfolio, and global and regional customer base, it will be able to capitalize on the expansion in flavors and fragrances markets, and deliver long-term growth. Focus on driving greater efficiencies throughout the business through costs and productivity initiatives, margin improvement, and acquisition-related synergies continue to drive profits.
International Flavors&#39; Solid Q2 Performance Instills Confidence: The company reported adjusted earnings of $1.16 per share in second-quarter 2024, which beat the Zacks Consensus Estimate of $1.01. The bottom line improved 15% from the year-ago quarter.
Currency-neutral sales grew 7% year over year, led by growth in the Scent, Health &amp; Biosciences and Nourish segments. The company reported volume growth in the high-single digits.
Growth Strategies Aid IFF Stock&#39;s Margins: In December 2022, International Flavors announced a new strategic and financial vision, which, among other things, consisted of a renewed growth-focus strategy, enhanced cost and productivity initiatives, and a redesigned operating model. It intends to transform its operating model into a more customer-centric and market-backed one. To this end, the company will conduct business in three core end markets &mdash; Food and Beverage, Home and Personal Care, and Health.
To drive growth, IFF plans to step up its investment in high-return businesses such as Flavors, Fragrances, Health, Cultures and Food Enzymes.&nbsp; It has continued to optimize its portfolio and completed the sale of Microbial Control, a portion of the Savory Solutions business and the Flavor Specialty Ingredients business.&nbsp; The company closed the sale of the Cosmetic Ingredients business to Clariant for $810 million at the end of 2023.
The unit includes the Lucas Meyers Cosmetics and IBR brands, and operates six research and development and/or production sites globally. Recently, International Flavors announced that it entered an agreement to sell its Pharma Solutions business, which is on track to close in the first half of 2025. These endeavors will help International Flavors focus on its core business operations, strengthen its balance sheet and maximize shareholder return.
Improved Volumes Enhances IFF&#39;s 2024 Outlook: The company&#39;s Functional Ingredients&nbsp; business is a leading global specialty food ingredients provider with a market leadership position in a broad portfolio of ingredients businesses, including Protein Solutions, Emulsifiers and Sweeteners, Core Texturant, and Cellulosic and Food Protection.
IFF is taking additional actions to rapidly improve the performance of its businesses,&nbsp; which is expected to lead to low-single-digit comparable currency-neutral sales growth, in line with the market. In the second quarter of 2024, the company reported volume growth in the high-single digits. This is likely to persist and boost its top line.
International Flavors expects sales of $11.1-$11.3 billion. Its prior expectation was near the higher end of $10.8-$11.1 billion. Volume is expected to rise 3-5%, reflecting improvement across all segments. The company earlier expected volume of 0-3%. It anticipates pricing to favor sales by 1% year over year. Adjusted EBITDA is expected between $2.1 billion and $2.17 billion, up from the previously stated $1.9-$2.1 billion.
<h2>Zacks Rank &amp; Other Stocks to Consider</h2>
International Flavors currently carries a Zacks Rank #2 (Buy).
Some other top-ranked stocks in the Consumer Staples sector are Ollie&#39;s Bargain Outlet Holdings, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/olli#NASDAQ">OLLI</a>), Edgewell Personal Care Co. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/epc#NYSE">EPC</a>) and Ingredion Incorporated (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/ingr#NYSE">INGR</a>). These three companies currently have a Zacks Rank #2.
Ollie&#39;s Bargain Outlet has an average trailing four-quarter earnings surprise of 7.9%. The Zacks Consensus Estimate for OLLI&#39;s 2024 earnings is pegged at $3.28 per share. This indicates a 12.7% increase from the prior-year reported figure. The consensus estimate for 2024 earnings has moved 1% north in the past 60 days. OLLI shares have gained 21.1% in the past year.
Edgewell Personal Care has an average trailing four-quarter earnings surprise of 88%. The Zacks Consensus Estimate for EPC&#39;s 2024 earnings is pegged at $3.00 per share. This indicates a 17.2% increase from the prior-year reported figure. The consensus estimate for 2024 earnings has moved 3% north in the past 60 days. EPC shares have gained 4.5% in the past year.
The Zacks Consensus Estimate for Ingredion&#39;s 2024 earnings per share is pegged at $9.95, indicating growth of 5.6% from the prior-year actual. Earnings estimates have moved 3% north in the past 60 days. It has an average trailing four-quarter earnings surprise of 10.9%. INGR shares have gained 34.6% in the past year.
<a href="https://www.zacks.com/stock/news/2330984/international-flavors-hits-52-week-high-what-s-aiding-the-stock?cid=CS-BENZ-FT-analyst_blog|52week_high/low-2330984">To read this article on Zacks.com click here.</a>

Large Cap

Mid Cap

Small Cap

OLLI

International Flavors Hits 52-Week High: What's Aiding the Stock?

Throughout the last three months, 4 analysts have evaluated Ingredion (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/INGR#NYSE">INGR</a>), offering a diverse set of opinions from bullish to bearish.
The following table encapsulates their recent ratings, offering a glimpse into the evolving sentiments over the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th style="text-align: right;">Bullish</th>
<th style="text-align: right;">Somewhat Bullish</th>
<th style="text-align: right;">Indifferent</th>
<th style="text-align: right;">Somewhat Bearish</th>
<th style="text-align: right;">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">2</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">2</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
</tbody>
</table>
Analysts' evaluations of 12-month price targets offer additional insights, showcasing an average target of $139.75, with a high estimate of $148.00 and a low estimate of $128.00. Surpassing the previous average price target of $127.25, the current average has increased by 9.82%.
<img src="https://www.benzinga.com/files/images/story/2024/1723730460_0.png" alt="price target chart" />
<h2>Breaking Down Analyst Ratings: A Detailed Examination</h2>
The standing of Ingredion among financial experts is revealed through an in-depth exploration of recent analyst actions. The summary below outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Cody Ross</td>
<td>UBS</td>
<td>Raises</td>
<td>Buy</td>
<td>$148.00</td>
<td>$141.00</td>
</tr>
<tr>
<td>Benjamin Theurer</td>
<td>Barclays</td>
<td>Raises</td>
<td>Overweight</td>
<td>$145.00</td>
<td>$122.00</td>
</tr>
<tr>
<td>Andrew Strelzik</td>
<td>BMO Capital</td>
<td>Raises</td>
<td>Market Perform</td>
<td>$128.00</td>
<td>$120.00</td>
</tr>
<tr>
<td>Kristen Owen</td>
<td>Oppenheimer</td>
<td>Raises</td>
<td>Outperform</td>
<td>$138.00</td>
<td>$126.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Responding to changing market dynamics and company performance, analysts update their recommendations. Whether they 'Maintain', 'Raise', or 'Lower' their stance, it signifies their response to recent developments related to Ingredion. This offers insight into analysts' perspectives on the current state of the company.</li>
<li>Rating: Gaining insights, analysts provide qualitative assessments, ranging from 'Outperform' to 'Underperform'. These ratings reflect expectations for the relative performance of Ingredion compared to the broader market.</li>
<li>Price Targets: Understanding forecasts, analysts offer estimates for Ingredion's future value. Examining the current and prior targets provides insight into analysts' changing expectations.</li>
</ul>
Navigating through these analyst evaluations alongside other financial indicators can contribute to a holistic understanding of Ingredion's market standing. Stay informed and make data-driven decisions with our Ratings Table.
<a href="https://www.benzinga.com/quote/INGR/analyst-ratings?utm_source=Benzinga Insights">Stay up to date on Ingredion analyst ratings.</a>
<h2>Discovering Ingredion: A Closer Look</h2>
Ingredion is an ingredients provider for the food, beverage, brewing, and animal nutrition industries. The company processes corn, tapioca, potatoes, stevia, grains, fruits, gums, and vegetables into value-added ingredients. The company has two main product lines: specialty and core ingredients. Specialty ingredients includes starch-based texturizers, natural alternative sweeteners such as stevia, and plant proteins for alternative dairy and snacks. Core ingredients includes sweeteners, such as high-fructose corn syrup, and commodity starches, such as those used for sustainable packaging.
<h3>Understanding the Numbers: Ingredion's Finances</h3>
Market Capitalization Analysis: The company's market capitalization is above the industry average, indicating that it is relatively larger in size compared to peers. This may suggest a higher level of investor confidence and market recognition.
Revenue Growth: Ingredion's revenue growth over a period of 3 months has faced challenges. As of 30 June, 2024, the company experienced a revenue decline of approximately -9.23%. This indicates a decrease in the company's top-line earnings. As compared to its peers, the revenue growth lags behind its industry peers. The company achieved a growth rate lower than the average among peers in Consumer Staples sector.
Net Margin: The company's net margin is a standout performer, exceeding industry averages. With an impressive net margin of 7.88%, the company showcases strong profitability and effective cost control.
Return on Equity (ROE): Ingredion's ROE excels beyond industry benchmarks, reaching 3.94%. This signifies robust financial management and efficient use of shareholder equity capital.
Return on Assets (ROA): Ingredion's financial strength is reflected in its exceptional ROA, which exceeds industry averages. With a remarkable ROA of 2.04%, the company showcases efficient use of assets and strong financial health.
Debt Management: The company maintains a balanced debt approach with a debt-to-equity ratio below industry norms, standing at 0.49.
<h2>Analyst Ratings: What Are They?</h2>
Within the domain of banking and financial systems, analysts specialize in reporting for specific stocks or defined sectors. Their work involves attending company conference calls and meetings, researching company financial statements, and communicating with insiders to publish "analyst ratings" for stocks. Analysts typically assess and rate each stock once per quarter.
Some analysts will also offer forecasts for metrics like growth estimates, earnings, and revenue to provide further guidance on stocks. Investors who use analyst ratings should note that this specialized advice comes from humans and may be subject to error.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

What 4 Analyst Ratings Have To Say About Ingredion

UBS analyst Cody Ross maintains Ingredion (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/INGR#NYSE">INGR</a>) with a Buy and raises the price target from $141 to $148.

UBS Maintains Buy on Ingredion, Raises Price Target to $148

Barclays analyst Benjamin Theurer upgrades Ingredion (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/INGR#NYSE">INGR</a>) from Equal-Weight to Overweight and raises the price target from $122 to $145.

Upgrades

Barclays Upgrades Ingredion to Overweight, Raises Price Target to $145

BMO Capital analyst Andrew Strelzik maintains Ingredion (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/INGR#NYSE">INGR</a>) with a Market Perform and raises the price target from $120 to $128.

BMO Capital Maintains Market Perform on Ingredion, Raises Price Target to $128

Oppenheimer analyst Kristen Owen maintains Ingredion (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/INGR#NYSE">INGR</a>) with a Outperform and raises the price target from $126 to $138.

Oppenheimer Maintains Outperform on Ingredion, Raises Price Target to $138

Ingredion shares are trading higher after the company reported better-than-expected Q2 adjusted EPS results.

Ingredion Sees FY24 Adj. EPS $9.70-$10.20

Barclays analyst Benjamin Theurer maintained a Buy rating on Ingredion (INGR – Research Report) today and set a price target of $145.00. The compan...

Barclays Keeps Their Buy Rating on Ingredion (INGR)

Tracking Yacktman Asset Management Portfolio - Q3 2024 Update

Ingredion Q3 2024 Earnings Preview

Here's the major earnings before the open tomorrow

Ingredion Non-GAAP EPS of $3.05 beats by $0.47, revenue of $1.87B misses by $70M

Reports Q3 revenue $1.87B, consensus $1.95B. "Texture & Healthful Solutions exhibited robust sales volume growth in the third quarter, which suppor...

Ingredion reports Q3 adjusted EPS $3.05, consensus $2.58

FY24 consensus $9.97. The company expects full-year 2024 net sales to be down mid-single-digits, excluding the effects of the sale of the South Kor...

Ingredion raises FY24 adjusted EPS view to $10.35-$10.65 from $9.70-$10.20

Oppenheimer analyst Kristen Owen maintained a Buy rating on Ingredion (INGR – Research Report) today and set a price target of $178.00. The company...

Ingredion (INGR) Receives a Buy from Oppenheimer

Oppenheimer raised the firm's price target on Ingredion (INGR) to $178 from $147 and keeps an Outperform rating on the shares. The firm notes the c...

Ingredion price target raised to $178 from $147 at Oppenheimer

BMO Capital analyst Andrew Strelzik raised the firm's price target on Ingredion (INGR) to $147 from $128 and keeps a Market Perform rating on the s...

Ingredion price target raised to $147 from $128 at BMO Capital

ACDC

AGCO

APLS

ARCH

BEAM

BLDP

BLDR

BOIVF

BRKR

CEIX

CNSL

CTSH

DHLGY

DNNGY

ENDPQ

EXPD

FANG

FOXA

GLDD

GOOG

GOOGL

HSIC

KPTI

LGIH

MITT

MLCO

MPLX

MSFT

NMRK

NWSA

NWSAL

ONIT

OXSQ

PMTS

PTLO

RACE

SCHW

SHIP

SNDL

SQNS

SSNLF

TCNNF

TRGP

UHAL

USAC

VWDRY

WLKP

Press Releases

Better Juice Gives Sorbets and Fruit Ice Creams a Sugar Reduction Revamp

Ingredion Releases 2023 Sustainability Report: Building a Sustainable Future. Together.

Ingredion to Release 2024 Second Quarter Financial Results on August 6, 2024

Ingredion Incorporated Reports Strong Second Quarter Results and Raises Full-Year Outlook

Ingredion Named a Finalist for the National Safety Council's Green Cross for Safety® Awards

Dividends

Ingredion Incorporated Declares Quarterly Dividend of $0.80 per Share

Ingredion to Release 2024 Third Quarter Financial Results on November 5, 2024

Restaurants

General

Companies partnering to improve plant-based cheese options

Ingredion to Webcast Industry-First Texture Innovation Day

Ingredion Incorporated Reports Strong Third Quarter Results and Raises Full-Year Outlook

Archer-Daniels-Midland Company Common Stock

Archer-Daniels Midland

AgriFORCE Growing Systems Ltd. - Common Shares

AgriFORCE Growing Systems

Alico

Bunge Global

Benson Hill

Cresud S.A.C.I.F. y A. - American Depositary Shares, each representing ten shares of Common Stock

Comments

Ingredion

Interés en corto

Ingredion (NYSE:INGR) Bolsa, Informe de interés en corto

La gente también mira

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL